SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-17-074453
Filing Date
2017-12-21
Accepted
2017-12-21 09:13:38
Documents
1
Group Members
GI EXECUTION SERVICES, LLCSUSQUEHANNA ADVISORS GROUP, INC.SUSQUEHANNA INVESTMENT GROUPSUSQUEHANNA SECURITIES

Document Format Files

Seq Description Document Type Size
1 SC 13G a17-28743_2sc13g.htm SC 13G 177487
  Complete submission text file 0001104659-17-074453.txt   179597
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Subject) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-54847 | Film No.: 171268133
SIC: 2834 Pharmaceutical Preparations

Mailing Address WINDWARD 1 REGATTA OFFICE PARK, WEST BAY ROAD GRAND CAYMAN E9 KY1-1103
Business Address WINDWARD 1 REGATTA OFFICE PARK, WEST BAY ROAD GRAND CAYMAN E9 KY1-1103 345-949-7576
CAPITAL VENTURES INTERNATIONAL (Filed by) CIK: 0001011712 (see all company filings)

IRS No.: 980158206 | Fiscal Year End: 1231
Type: SC 13G